Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone deacetylase activity

HDAC9 HDAC4

7.15e-0424332GO:0004407
GeneOntologyMolecularFunctionprotein lysine deacetylase activity

HDAC9 HDAC4

7.76e-0425332GO:0033558
GeneOntologyMolecularFunctionmicrofilament motor activity

MYH7B MYO19

1.79e-0338332GO:0000146
GeneOntologyMolecularFunctionhistone deacetylase binding

HDAC9 SATB2 HDAC4

1.81e-03147333GO:0042826
GeneOntologyMolecularFunctiondeacetylase activity

HDAC9 HDAC4

1.99e-0340332GO:0019213
GeneOntologyBiologicalProcessregulation of skeletal muscle cell differentiation

HDAC9 HDAC4 MCUB

1.42e-0528353GO:2001014
GeneOntologyBiologicalProcesspeptidyl-lysine deacetylation

HDAC9 HDAC4

4.18e-056352GO:0034983
GeneOntologyBiologicalProcessregulation of skeletal muscle fiber differentiation

HDAC9 HDAC4

5.84e-057352GO:1902809
GeneOntologyCellularComponentcentrosome

ASPM CEP104 CCDC15 ZNF12 BBS4 IFT81 CNTRL

2.44e-04770357GO:0005813
GeneOntologyCellularComponenthistone deacetylase complex

HDAC9 SATB2 HDAC4

3.87e-0485353GO:0000118
GeneOntologyCellularComponentmeiotic spindle

ASPM CNTRL

4.57e-0419352GO:0072687
GeneOntologyCellularComponentmicrotubule organizing center

ASPM CEP104 CCDC15 ZNF12 BBS4 IFT81 CNTRL

7.09e-04919357GO:0005815
DomainHist_deacetylase_Gln_rich_N

HDAC9 HDAC4

1.02e-053352IPR024643
DomainHDAC4_Gln

HDAC9 HDAC4

1.02e-053352PF12203
DomainHistone_deAcase_II_euk

HDAC9 HDAC4

2.04e-054352IPR017320
DomainHis_deacetylse_dom

HDAC9 HDAC4

1.86e-0411352IPR023801
DomainHist_deacetyl

HDAC9 HDAC4

1.86e-0411352PF00850
Domain-

HDAC9 HDAC4

1.86e-04113523.40.800.20
DomainHis_deacetylse

HDAC9 HDAC4

1.86e-0411352IPR000286
DomainIQ

ASPM MYH7B MYO19

4.65e-0481353SM00015
DomainMyosin-like_IQ_dom

ASPM MYH7B

5.72e-0419352IPR027401
Domain-

ASPM MYH7B

5.72e-04193524.10.270.10
DomainIQ_motif_EF-hand-BS

ASPM MYH7B MYO19

6.33e-0490353IPR000048
DomainIQ

ASPM MYH7B MYO19

6.97e-0493353PS50096
Domainzf-C2H2

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

1.65e-03693356PF00096
DomainMYOSIN_MOTOR

MYH7B MYO19

2.30e-0338352PS51456
DomainMyosin_head

MYH7B MYO19

2.30e-0338352PF00063
DomainMyosin_head_motor_dom

MYH7B MYO19

2.30e-0338352IPR001609
DomainMYSc

MYH7B MYO19

2.30e-0338352SM00242
Domainzf-C2H2_6

ZNF12 ZNF493 ZNF184 ZNF256

2.72e-03314354PF13912
DomainZINC_FINGER_C2H2_2

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

2.90e-03775356PS50157
DomainZINC_FINGER_C2H2_1

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

2.94e-03777356PS00028
DomainZnf_C2H2-like

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

3.31e-03796356IPR015880
DomainZnf_C2H2

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

3.50e-03805356IPR007087
DomainZnF_C2H2

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

3.57e-03808356SM00355
DomainARM-type_fold

ASPM CEP104 DOCK11 WDFY4

3.58e-03339354IPR016024
Domain-

ASPM CEP104 WDFY4

8.19e-032223531.25.10.10
Domain-

ZNF12 ZNF493 ZBTB1 ZNF184 ZNF256

8.23e-036793553.30.160.60
DomainZnf_C2H2/integrase_DNA-bd

ZNF12 ZNF493 ZBTB1 ZNF184 ZNF256

9.00e-03694355IPR013087
DomainGalactose-bd-like

CEP104 GLB1L3

1.34e-0294352IPR008979
DomainARM-like

ASPM CEP104 WDFY4

1.39e-02270353IPR011989
PathwayBIOCARTA_RANBP2_PATHWAY

HDAC9 HDAC4

2.22e-0411292M22027
PathwayWP_BARDETBIEDL_SYNDROME

CEP104 BBS4 IFT81

7.64e-0488293M45557
PathwayWP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR

CEP104 BBS4 IFT81

1.21e-03103293M39826
PathwayREACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY

HDAC9 HDAC4

1.49e-0328292M6177
PathwayWP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS

HDAC9 HDAC4

1.83e-0331292M39714
PathwayREACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT

SATB2 HDAC4

1.83e-0331292M27805
PathwayWP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR

HDAC9 HDAC4

1.95e-0332292M39521
PathwayPID_HDAC_CLASSII_PATHWAY

HDAC9 HDAC4

2.20e-0334292M30
PathwayWP_ALSTROM_SYNDROME

IFT81 VCPIP1

2.20e-0334292M45524
PathwayWP_2Q112_COPY_NUMBER_VARIATION_SYNDROME

KANSL3 TMEM127

2.33e-0335292M45521
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KANSL3 CEP104 TRIM33 RNF40 SATB2 ZNF592 VPS39

1.03e-0652936714621295
Pubmed

Dephosphorylation at a conserved SP motif governs cAMP sensitivity and nuclear localization of class IIa histone deacetylases.

HDAC9 HDAC4

3.12e-06336223297420
Pubmed

The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.

HDAC9 HDAC4

3.12e-06336228419090
Pubmed

HDAC4 deacetylase associates with and represses the MEF2 transcription factor.

HDAC9 HDAC4

3.12e-06336210487761
Pubmed

Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells.

HDAC9 HDAC4

3.12e-06336231754707
Pubmed

HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.

HDAC9 HDAC4

3.12e-06336227333946
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

RNF40 ZNF592 DOCK11 ZBTB1 VPS39 ESF1

5.60e-0644036634244565
Pubmed

Class IIa histone deacetylases: conducting development and differentiation.

HDAC9 HDAC4

6.24e-06436219412888
Pubmed

mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity.

HDAC9 HDAC4

6.24e-06436210748098
Pubmed

HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.

HDAC9 HDAC4

6.24e-06436210523670
Pubmed

Deacetylation of Glutaminase by HDAC4 contributes to Lung Cancer Tumorigenesis.

HDAC9 HDAC4

6.24e-06436235864951
Pubmed

Disruption of Aspm causes microcephaly with abnormal neuronal differentiation.

ASPM SATB2

6.24e-06436224220505
Pubmed

Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.

HDAC9 HDAC4

1.04e-05536215194749
Pubmed

Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4.

HDAC9 HDAC4

1.04e-05536218332106
Pubmed

Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor.

HDAC9 HDAC4

1.04e-05536219893013
Pubmed

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.

RNF40 MGAT1 MCUB VPS39 CNTRL

1.09e-0528536532838362
Pubmed

Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4.

HDAC9 HDAC4

1.56e-05636210825153
Pubmed

Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation.

HDAC9 HDAC4

1.56e-05636216356933
Pubmed

Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.

HDAC9 HDAC4

2.18e-05736211022042
Pubmed

The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase.

HDAC9 HDAC4

2.18e-05736212032081
Pubmed

Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers.

HDAC9 HDAC4

2.91e-05836217786239
Pubmed

Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.

HDAC9 HDAC4

2.91e-05836216288017
Pubmed

Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation.

HDAC9 HDAC4

2.91e-05836212242305
Pubmed

The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.

HDAC9 HDAC4

3.73e-05936216260608
Pubmed

Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.

HDAC9 HDAC4

3.73e-05936211466315
Pubmed

Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development.

HDAC9 HDAC4

3.73e-05936215367668
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

HDAC9 CCDC15 TRIM33 RNF40 ZNF592 VPS39 IFT81 VCPIP1

4.08e-05128536835914814
Pubmed

Class II histone deacetylases: versatile regulators.

HDAC9 HDAC4

4.66e-051036212711221
Pubmed

Histone Deacetylase 1 Is Essential for Rod Photoreceptor Differentiation by Regulating Acetylation at Histone H3 Lysine 9 and Histone H4 Lysine 12 in the Mouse Retina.

HDAC9 HDAC4

4.66e-051036228028172
Pubmed

MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration.

HDAC9 HDAC4

5.70e-051136231223056
Pubmed

Neural metabolic imbalance induced by MOF dysfunction triggers pericyte activation and breakdown of vasculature.

KANSL3 SATB2

5.70e-051136232541879
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

RNF40 SATB2 ZNF592 ZBTB1 VCPIP1

6.79e-0541836534709266
Pubmed

Kinase signalling in excitatory neurons regulates sleep quantity and depth.

HDAC9 HDAC4

6.83e-051236236477539
Pubmed

Loss of Aspm causes increased apoptosis of developing neural cells during mouse cerebral corticogenesis.

ASPM SATB2

8.07e-051336238019816
Pubmed

Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.

HDAC9 HDAC4

8.07e-051336222693459
Pubmed

Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.

HDAC9 HDAC4

9.41e-051436215964851
Pubmed

Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.

HDAC9 HDAC4

9.41e-051436221953612
Pubmed

The histone deacetylase 9 gene encodes multiple protein isoforms.

HDAC9 HDAC4

9.41e-051436212590135
Pubmed

Histone deacetylase expression patterns in developing murine optic nerve.

HDAC9 HDAC4

9.41e-051436225011550
Pubmed

Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin.

HDAC9 HDAC4

9.41e-051436215601857
Pubmed

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.

HDAC9 HDAC4

9.41e-051436215537544
Pubmed

Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.

HDAC9 HDAC4

1.24e-041636216873063
Pubmed

Disruptions in asymmetric centrosome inheritance and WDR62-Aurora kinase B interactions in primary microcephaly.

ASPM SATB2

1.58e-041836228272472
Pubmed

HDAC family: What are the cancer relevant targets?

HDAC9 HDAC4

1.58e-041836218824292
Pubmed

Smad4 and Trim33/Tif1γ redundantly regulate neural stem cells in the developing cortex.

TRIM33 SATB2

1.58e-041836223765158
Pubmed

Centrosome-related genes, genetic variation, and risk of breast cancer.

ASPM BBS4 CNTRL

1.63e-0410236320508983
Pubmed

Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias.

ASPM SATB2

1.96e-042036234237032
Pubmed

Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.

HDAC9 HDAC4

1.96e-042036221421818
Pubmed

An atlas of combinatorial transcriptional regulation in mouse and man.

HDAC9 ZNF12 HDAC4 ZNF592 ZBTB1 ZNF184

2.58e-0487736620211142
Pubmed

Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

TRIM33 SATB2 ZBTB1

2.97e-0412536332891193
Pubmed

Conserved transcriptional regulation by BRN1 and BRN2 in neocortical progenitors drives mammalian neural specification and neocortical expansion.

ASPM SATB2

3.08e-042536239271675
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

ASPM KANSL3 TRIM33 RNF40 VCPIP1

3.32e-0458836538580884
Pubmed

VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

ASPM SATB2

3.60e-042736221737879
Pubmed

Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.

CEP104 CCDC15 CNTRL

4.67e-0414636321399614
Pubmed

Embryonic forebrain transcriptome of mice with polyalanine expansion mutations in the ARX homeobox gene.

ASPM HDAC4

4.75e-043136227798109
Pubmed

Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.

HDAC9 MYH7B

4.75e-043136221985497
Pubmed

Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.

USP48 VPS39 VCPIP1

4.77e-0414736329576527
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

KANSL3 TRIM33 RNF40 USP48 ZNF592 ESF1

5.58e-04101436632416067
Pubmed

An Oct4-centered protein interaction network in embryonic stem cells.

KANSL3 TRIM33 SATB2

6.91e-0416736320362541
Pubmed

WDR62 is required for centriole duplication in spermatogenesis and manchette removal in spermiogenesis.

ASPM SATB2

7.15e-043836234059773
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

KANSL3 RNF40 MGAT1 TMEM127 ZNF592 VPS39

8.74e-04110536635748872
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

TRIM33 ZNF592 VCPIP1

9.15e-0418436332908313
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

ZNF12 TRIM33 RNF40 VPS39 CNTRL

1.02e-0375436535906200
InteractionS100A4 interactions

SATB2 WDFY4 VPS39 CNTRL VCPIP1

5.48e-06144365int:S100A4
InteractionKRT38 interactions

ASPM TRIM33 RNF40 HDAC4 VCPIP1

1.30e-05172365int:KRT38
GeneFamilyHistone deacetylases, class IIA

HDAC9 HDAC4

9.27e-064232992
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF12 ZNF493 ZNF592 ZBTB1 ZNF184 ZNF256

2.17e-0471823628
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KANSL3 HDAC9 MYO19 STYK1

9.83e-06167364a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KANSL3 HDAC9 MYO19 STYK1

9.83e-06167364528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCellCOVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

HDAC9 DOCK11 WDFY4 CNTRL

1.47e-05185364e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM HDAC9 WDFY4 CNTRL

1.53e-0518736473931a5ea73799095daff100b5f18853c57c74dc
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC9 DOCK11 WDFY4 CNTRL

1.77e-05194364c95d5c4ad0210ebd672926558cc8331e6396a854
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC9 MGAT1 DOCK11 WDFY4

1.81e-05195364247803cf58c6d9c561a52aa34e581188ddad197e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MCUB DOCK11 WDFY4 CNTRL

1.81e-051953647b6c69df943842b566a596e30bb50dbe80dccc83
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC9 DOCK11 WDFY4 CNTRL

1.84e-05196364cbc727b55b6433a701b1a331028a49960fcee6ee
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC9 DOCK11 WDFY4 CNTRL

1.88e-051973646ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC9 MCUB DOCK11 WDFY4

1.88e-0519736461ef3f417767c3f5296a26399da63e3e4f58faf8
ToppCellChildren_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor

HDAC9 MGAT1 DOCK11 WDFY4

1.88e-05197364f18807124b91310fcd84238484a80ecdba684679
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells)

MYH7B ZNF256 STYK1

2.25e-041473633ed5b020ce1f1277917d79ef1f7da53fa474e8db
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

HDAC9 WDFY4 MYH7B

2.35e-0414936371d72a6e7b128ee96161e08f6a0d77be925e73a1
ToppCellPND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HDAC9 MCUB WDFY4

2.49e-04152363c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3
ToppCellPND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HDAC9 MCUB WDFY4

2.49e-04152363c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d
ToppCellPND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HDAC9 MCUB WDFY4

2.49e-04152363cefc0ab592e99badf145fb95adf9906cb81be81c
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PTER MCUB EFCAB13

2.58e-041543630066b2b8cfc74603e97f271ef5efc7ec512110dc
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SATB2 PTER MCUB

2.73e-041573635aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SATB2 PTER MCUB

2.89e-04160363d8241404d775f9a709abdf17988f36293fcf4c58
ToppCell367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ASPM CCDC15 CCDC30

2.94e-04161363c61283c301a87bb802f6f8ce79c26067032dd7d9
ToppCell367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ASPM CCDC15 CCDC30

2.94e-041613639864d8b0929dacf4be7a4e97d2527ac3120ea264
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HDAC9 MYO19 STYK1

3.05e-041633637a04192710f55acf5a4681d5f09942358fdb02ff
ToppCellICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type

CEP104 ZNF256 EFCAB13

3.22e-04166363d3fa2e42497201f1ca57f4f977fbaa0def950033
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HDAC9 MYH7B ZNF256

3.22e-04166363c8fd241088de27c6e741a5dfee3cd770183b6bcb
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SATB2 PTER MCUB

3.28e-04167363f1ce6e64ebede1f3ef36fe982f46919fd1f814dd
ToppCellLPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.34e-04168363eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCellLPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.34e-04168363063d0368d656962b335154c230bdcd9236e7c9ad
ToppCellLPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.34e-04168363a7c4251d8a83bc30196a444028a35c17c24dc291
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM HDAC9 WDFY4

3.39e-0416936354b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCellLPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.45e-0417036356284fbfd1e53f67c8c0b7fba64505a4002adba2
ToppCellLPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.45e-0417036392e0873f618b2fa60c4d555b10f234d5cbcf3325
ToppCellLPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.45e-04170363c181991f933b779f99afc3782f292306f209e2ac
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

WDFY4 ESF1 CNTRL

3.45e-0417036332917888c3f1d54302675c1d4de1fd3b7c79af5f
ToppCell356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

HDAC9 WDFY4 ZNF256

3.51e-041713633d60e7ecf25e4b781ba2387671b2aad247fb75ff
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

HDAC9 WDFY4 CNTRL

3.63e-04173363d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCellLPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.70e-04174363b4c2d1c029fcd0d4926aa79a5b789c713919dcf3
ToppCellLPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.70e-04174363cc493654ea3517bc6a145c7f787f304929636f86
ToppCellLPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.70e-041743639eb3504f9340517ef5d056503044fbdb9ffeb714
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SATB2 PTER EFCAB13

3.82e-04176363a1b9f8f199a028b3fa85de43fe96bc29f387bfd8
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC9 MCUB WDFY4

3.82e-04176363926ed37e636fe4dd3a18731cea15761f0c2c285a
ToppCellLPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.88e-041773635ed65e08d773d157840317c72e0d43c261d438d4
ToppCellLPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.88e-04177363c82332c5f656aa26513e4f7525d5d4d733019725
ToppCellLPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HDAC9 MCUB WDFY4

3.88e-041773638a955a7ab84c434f9ad4b467246b8be3cb479406
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SATB2 PTER MCUB

3.95e-041783636f61490d79cd1727ed2d5cc673823dd4efdafac1
ToppCellPND10-Immune-Immune_Myeloid-Dendritic-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ASPM MCUB WDFY4

4.28e-04183363ab38264daddccdf5ffb75ff2210b27423eca6bc0
ToppCellPND10-Immune-Immune_Myeloid-Dendritic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ASPM MCUB WDFY4

4.28e-04183363e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c
ToppCellPND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ASPM MCUB WDFY4

4.28e-04183363263bfa1d8a7314bc3156c735c403c3bab8ea4dac
ToppCellCOVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations)

ASPM HDAC9 USP48

4.28e-04183363130c109f63a5e3c8f83cb96e32f4addf513b6415
ToppCellCOVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations)

ASPM HDAC9 USP48

4.28e-041833632c016bb59f131a0e821853b085289a3583f0a729
ToppCellnucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HDAC9 USP48 WDFY4

4.35e-04184363942b58ae7172bb5f97e55b032db9329d161854af
ToppCellnucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HDAC9 USP48 WDFY4

4.35e-04184363911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCellCOVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type

ASPM HDAC9 USP48

4.49e-0418636366676d9395172de5707e204826a1c9f73b448cca
ToppCelldroplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BBS4 IFT81 ZNF184

4.49e-04186363f5468e03321ea2083e223eb0d92c3a9307039569
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 CCDC30 EFCAB13

4.49e-04186363f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 DOCK11 EFCAB13

4.70e-041893633b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCellCOVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type

HDAC9 DOCK11 WDFY4

4.70e-041893632586f4088721c5debec86c2b211b739fd33713eb
ToppCellCF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class

USP48 WDFY4 CNTRL

4.78e-04190363374d8fd63c733178acab07682ed1519693efab45
ToppCellControl-Myeloid|Control / group, cell type (main and fine annotations)

MGAT1 DOCK11 WDFY4

4.85e-041913639c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 DOCK11 EFCAB13

4.85e-04191363d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCellCOVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type

MGAT1 DOCK11 WDFY4

4.85e-04191363dab953682b8c9ed680a799161f837f792a7e4f33
ToppCellCOVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type

MGAT1 DOCK11 WDFY4

4.92e-04192363bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCellRV-08._Macrophage|World / Chamber and Cluster_Paper

ASPM DOCK11 WDFY4

4.92e-04192363a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 PTER FBXL21P

4.92e-041923633e1a4cb0d83efd502c8613d41a1692bdda5860ed
ToppCellControl-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations)

MGAT1 DOCK11 WDFY4

5.00e-04193363a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCellRV-08._Macrophage|RV / Chamber and Cluster_Paper

ASPM DOCK11 WDFY4

5.00e-0419336312bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCellCF-Lymphoid|CF / Disease state, Lineage and Cell class

USP48 WDFY4 CNTRL

5.00e-0419336311de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 DOCK11 FBXL21P

5.08e-041943638ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCellChildren_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor

MGAT1 DOCK11 WDFY4

5.08e-0419436369cf7c989ac355c459db13f9d4267b55adc3c174
ToppCell(7)_MNP-(7)_DC_1|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)

ASPM HDAC9 WDFY4

5.08e-041943638dbe0188e2af6f14b3b44e5213fbdd581128082f
ToppCellImmune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor

MGAT1 DOCK11 WDFY4

5.15e-04195363f92114ef995e690a3bedc62c89c5fd6773d0d9f7
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor

MGAT1 DOCK11 WDFY4

5.15e-0419536355e25f702af19146a161861cfd15f40bbda1dc35
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type

MGAT1 DOCK11 WDFY4

5.23e-041963637026c1fc33425e5476063d17c79e4b79356a9e01
ToppCellCOVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

MGAT1 DOCK11 WDFY4

5.31e-04197363e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCellCOVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type

MGAT1 DOCK11 WDFY4

5.31e-041973633896729740d151f0eb845f1961c7b969bfbdd28d
ToppCellAdult-Immune|Adult / Lineage, Cell type, age group and donor

MGAT1 DOCK11 WDFY4

5.39e-041983639bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCellParenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 WDFY4 VCPIP1

5.39e-04198363fa5c15a656d4132950092919600e270f1fd79abf
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 DOCK11 WDFY4

5.39e-04198363863765ccc0205dc28864dae85af339c283194c96
ToppCellImmune|World / Lineage, Cell type, age group and donor

MGAT1 DOCK11 WDFY4

5.39e-0419836365681b54d13c6997bd90a1c2a12314a80e964fe3
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ASPM HDAC9 WDFY4

5.39e-04198363732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCellcritical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CCDC30 IFT81 CNTRL

5.39e-04198363ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCellFetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HDAC9 DOCK11 WDFY4

5.39e-041983635dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCell(11)_FOXN4+|World / shred by cell type by condition

ASPM IFT81 CNTRL

5.39e-04198363516b1acdf997dd8debc3dca066519366e507b414
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 DOCK11 WDFY4

5.39e-04198363824461cf44098440ba8bc0df96735423ac65bda1
ToppCellLPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ASPM CCDC15 CNTRL

5.46e-0419936398575fcce726589e93fbb4df1aab03e57cb56076
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 MGAT1 WDFY4

5.55e-0420036378d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell390C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

HDAC9 MGAT1 WDFY4

5.55e-042003633935b6ff3ae32d170a268538c756ee34ed2308d4
ToppCellControl-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class

ASPM KANSL3 CEP104

5.55e-04200363118321ac443feb42aee171baccfc4610f00a8822
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MGAT1 DOCK11 WDFY4

5.55e-04200363a443e475e7a10c26a6173d1af961de6219e0e567
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 MGAT1 WDFY4

5.55e-04200363ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCellSigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass

ASPM HDAC9 STYK1

5.55e-042003634e489ecf472857357d45e9f6c7a812aa48b72ebf
ToppCellParenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

KANSL3 HDAC9 ZNF592

5.55e-04200363a372ef3f9e6ff6e3c3376d6e10182977c5067788
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MGAT1 DOCK11 WDFY4

5.55e-04200363ed785a6d08ca2b350dc3307b587eadfb2886d1f9
ToppCellBronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 MGAT1 WDFY4

5.55e-042003635432bdf495431cd26f6e4cd585100f3652588913
ToppCellParenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HDAC9 MGAT1 WDFY4

5.55e-04200363b4277b6faa69f20974696c7c422311f5c89e3663
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK-MAIT|ICU-NoSEP / Disease, condition lineage and cell class

CEP104 ZNF256 EFCAB13

5.55e-042003634f03b5f4110ed1637ffe17cb6ff309265a3af9a8
ComputationalGenes in the cancer module 257.

RNF40 MGAT1 VPS39 MYH7B

1.73e-04156204MODULE_257
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A

CEP104 RNF40 HDAC4 IFT81 CNTRL

1.30e-051943651219_DN
Drug5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA

BBS4 HDAC4 USP48 MYO19 CNTRL

1.43e-05198365950_DN
Drugms-27

HDAC9 HDAC4

2.42e-055362CID016122504
Diseasebipolar I disorder

ZNF592 MYO19 IFT81

6.79e-04141363EFO_0009963
Diseasecomplement factor H-related protein 4 measurement

ASPM MGAT1

1.64e-0349362EFO_0600091
Diseasefasting blood insulin measurement

ZNF12 GLB1L3

3.23e-0369362EFO_0004466
Diseasebipolar disorder

SEMG1 HDAC9 IFT81 ZNF184

5.19e-03577364MONDO_0004985
Diseasemiddle cerebral artery infarction (biomarker_via_orthology)

HDAC9 HDAC4

5.77e-0393362DOID:3525 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
QNHNHQLKGDAQRYK

RNF40

491

O75150
IYLKQFNKAQDQLHN

BBS4

146

Q96RK4
KQQLKDFQNHLNHVV

CNTRL

786

Q7Z7A1
HAYKAQVNQRKNFLQ

ASPM

1786

Q8IZT6
VIQQQHQQFLEKHKQ

HDAC4

481

P56524
HQQFLEKHKQQFQQQ

HDAC4

486

P56524
QFFHKKSKQQHFDVQ

MCUB

286

Q9NWR8
KSKQQHFDVQQYNKL

MCUB

291

Q9NWR8
DQHLKFIKLNQQFVH

MGAT1

326

P26572
INYANEKLQQHFVAH

MYO19

431

Q96H55
NLQKLHQDTFNQLHK

GLB1L3

276

Q8NCI6
KHFNYNKIVEHQNLS

ESF1

721

Q9H501
QQANTNLAKYRKAQH

MYH7B

1936

A7E2Y1
QKNAYSHKENLQLNQ

PTER

61

Q96BW5
KLIFHQNHVNKYNIY

CEP104

126

O60308
YLAQQKQEQKNQLFH

IFT81

221

Q8WYA0
IKHAFDTRYQHKNQQ

DOCK11

1146

Q5JSL3
VHVRNYNEKHHQQKV

CCDC30

496

Q5VVM6
QYNMNIKQHKISLHN

EFCAB13

941

Q8IY85
HKQAQAQFAAFLKQN

KANSL3

576

Q9P2N6
QQHQQFLEKQKQYQQ

HDAC9

466

Q9UKV0
QQIIKKHFAHLQYVS

FBXL21P

106

Q9UKT6
LQHMQQQVYAQKHQQ

TRIM33

516

Q9UPN9
LVYNKNQHQTKNLNQ

SEMG1

261

P04279
KHTIIKFFQNQRYHV

SATB2

656

Q9UPW6
KHFQKQVKYRVNQQI

CCDC15

81

Q0P6D6
QFHQYLGKHKNLVQL

STYK1

166

Q6J9G0
NKKRHIQQHFYQNVS

ZNF592

871

Q92610
QLQFTAYLHQHQKQH

ZNF256

126

Q9Y2P7
KNLQAFQVLQNVFHK

WDFY4

381

Q6ZS81
NLKQHFQQHLARYQA

VCPIP1

241

Q96JH7
FRDNHYQINSIQKKQ

ZBTB1

511

Q9Y2K1
YVKVFHKLLNSNRHN

ZNF493

31

Q6ZR52
GKNFYQKLHLIQHQR

ZNF12

331

P17014
RQKISHQNYIAYQKQ

USP48

916

Q86UV5
AQQQQHKKYHGSQVY

TMEM127

156

O75204
NLNQHQKTHTQEKAY

ZNF184

516

Q99676
KQQQIHHIKNLYAFN

VPS39

341

Q96JC1